CXCR4, a subclass of chemokine receptors, contributed to AAA formation, and its blockade by AMD3100, a potent CXCR4 antagonist, inhibited AAA expansion by reducing the infiltration of adventitial macrophages and aortic wall destruction in a mouse model67. Here, CXCR4 is linked to triple-A syndrome.